Form 4 holding
President & CEO, Director
Coherus Oncology, Inc.
- Security class
- Common Stock
- Shares / value
- 1,048,235
- Estimated value
- $1,488,493
- Report date
- 23 Jan 2026
- Price
- $1.42
- Ownership
- Direct
Dennis M. Lanfear - President & CEO, Director at Coherus Oncology, Inc.
Issuer-level insider activity
- Role
- President & CEO, Director
- Issuer ticker
- CHRS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Dennis M. Lanfear since 13 Sep 2025
Reported holdings for Dennis M. Lanfear in Coherus Oncology, Inc.
Form 4 holding
President & CEO, Director
Coherus Oncology, Inc.
- Security class
- Common Stock
- Shares / value
- 432,684
- Estimated value
- $614,411
- Report date
- 23 Jan 2026
- Price
- $1.42
- Ownership
- By Trust
Form 4 holding
President & CEO, Director
Coherus Oncology, Inc.
- Security class
- Common Stock
- Shares / value
- 86,965
- Estimated value
- $123,490
- Report date
- 23 Jan 2026
- Price
- $1.42
- Ownership
- By LLC
Form 4 holding
President & CEO, Director
Coherus Oncology, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 225,000
- Estimated value
- Report date
- 29 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Dennis M. Lanfear in Coherus Oncology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.